Literature DB >> 32158665

Rhino-Orbital-Cerebral Mucormycosis: Battle with the Deadly Enemy.

Saroj Gupta1, Rashmi Goyal2, Navinchandra M Kaore3.   

Abstract

To study the clinical presentation and management outcomes in a series of patients with invasive rhino-orbital-cerebral mucormycosis presenting to a tertiary care center in central India. Medical records of eleven consecutive cases of invasive rhino-orbital-cerebral mucormycosis were reviewed. All clinically diagnosed cases, confirmed on microbiological examination were included. Their demographic data, clinical manifestations, underlying systemic conditions, microbiological and radiological reports, medical treatments, and surgical interventions were recorded and analyzed. There were nine male and two female patients with mean age of 46.8 years. Uncontrolled diabetes mellitus was noted in all patients. One patient had history of renal transplantation. The common presenting features were-ophthalmoplegia (73%), diminution of vision, (64%) proptosis (36%) and periorbital swelling (27%). CT scan/MRI revealed sino-orbital involvement in eight cases and rhino-orbital-cerebral involvement in three cases. Ethmoid sinus (100%) was the commonest paranasal sinus involved. KOH preparation and histopathology revealed broad aseptate filamentous fungi branching at right angles with tissue invasion. Culture on sabouraud's dextrose agar showed growth of mucor species. All patients received intravenous amphotericin B and had undergone radical debridement of involved sinuses. The mean duration of follow up was 13 months. All survived except three, who developed cerebral mucormycosis. Rhino-orbital-cerebral mucormycosis is a fetal fungal infection requiring multidisciplinary approach. Uncontrolled diabetes mellitus is the main predisposing factor. Early diagnosis, reversal of predisposing co-morbidities, aggressive medical and surgical management are vital in managing this highly aggressive disease. © Association of Otolaryngologists of India 2019.

Entities:  

Keywords:  Diabetes mellitus; Mucormycosis; Ophthalmoplegia; Orbital apex syndrome; Orbital cellulitis

Year:  2019        PMID: 32158665      PMCID: PMC7040141          DOI: 10.1007/s12070-019-01774-z

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  28 in total

Review 1.  Update on mucormycosis pathogenesis.

Authors:  Ashraf S Ibrahim; Dimitrios P Kontoyiannis
Journal:  Curr Opin Infect Dis       Date:  2013-12       Impact factor: 4.915

2.  A prospective study of mucormycosis in north India: experience from a tertiary care hospital.

Authors:  Kiran Bala; Jagdish Chander; Uma Handa; Rajpal Singh Punia; Ashok Kumar Attri
Journal:  Med Mycol       Date:  2015-01-13       Impact factor: 4.076

3.  Orbital mucormycosis (phycomycosis) (a survival with amphotericin-B and potassium iodide).

Authors:  R K Grewal; S S Grewal; R M Zachariah
Journal:  Indian J Ophthalmol       Date:  1985 Jul-Aug       Impact factor: 1.848

4.  Rhinocerebral mucormycosis: evolution of the disease and treatment options.

Authors:  K L Peterson; M Wang; R F Canalis; E Abemayor
Journal:  Laryngoscope       Date:  1997-07       Impact factor: 3.325

5.  A case of chronic progressive rhinocerebral mucormycosis treated with liposomal amphotericin B and surgery.

Authors:  M Ericsson; M Anniko; H Gustafsson; C A Hjalt; R Stenling; A Tärnvik
Journal:  Clin Infect Dis       Date:  1993-04       Impact factor: 9.079

Review 6.  Novel perspectives on mucormycosis: pathophysiology, presentation, and management.

Authors:  Brad Spellberg; John Edwards; Ashraf Ibrahim
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

7.  Diagnosis and management of rhino-orbitocerebral mucormycosis (phycomycosis). A report of 16 personally observed cases.

Authors:  A P Ferry; S Abedi
Journal:  Ophthalmology       Date:  1983-09       Impact factor: 12.079

8.  Rhinocerebral mucormycosis: results of aggressive surgical debridement and amphotericin B.

Authors:  J W Ochi; J P Harris; J I Feldman; G A Press
Journal:  Laryngoscope       Date:  1988-12       Impact factor: 3.325

9.  A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially.

Authors:  Nan Jiang; Guiqiu Zhao; Shanshan Yang; Jing Lin; Liting Hu; Chengye Che; Qian Wang; Qiang Xu
Journal:  BMC Ophthalmol       Date:  2016-01-12       Impact factor: 2.209

10.  Rhino-orbital Mucormycosis: Clinical Findings and Treatment Outcomes of Four Cases.

Authors:  Şeyda Karadeniz Uğurlu; Sedat Selim; Aylin Kopar; Murat Songu
Journal:  Turk J Ophthalmol       Date:  2015-08-05
View more
  13 in total

1.  Mucormycosis in Different Clinical Settings: A Case Series.

Authors:  Tareq Esteak; Rabeea Shah; Maha Tosaddeque; Shameem Behram; Muhammad Nasir
Journal:  Cureus       Date:  2022-04-23

2.  Histopathological Study of Mucormycosis in Post COVID-19 Patients and Factors Affecting it in a Tertiary Care Hospital.

Authors:  I Sree Lakshmi; B Swapna Kumari; Ch Jyothi; M Devojee; K Padma Malini; Padma Sunethri; Shrinivas Bheemrao Somalwar; T Kavitha
Journal:  Int J Surg Pathol       Date:  2022-06-06       Impact factor: 1.358

Review 3.  Rhinocerebral Mucormycosis as a Sequelae of COVID-19 Treatment: A Case Report & Literature Review.

Authors:  Andrew J Deek; Stefanos Boukovalas; Christopher J Rathfoot; Jack E Gotcher
Journal:  J Oral Maxillofac Surg       Date:  2021-09-20       Impact factor: 1.895

4.  Rhinocerebral mucormycosis in a diabetes type 2 patient: A fatal case report from northern Tanzania.

Authors:  Desderius Celestine Chussi; Michael Kayuza; Marco Magwizi; Peter Shija; Adnan Sadiq; Patrick Amsi; Denis Katundu; Philbert Mtenga
Journal:  SAGE Open Med Case Rep       Date:  2022-02-21

5.  Atypical presentations of fungal osteomyelitis during post COVID-19 outbreak - Case series.

Authors:  Ankita Chugh; Akhilesh Kumar Pandey; Amit Goyal; Kapil Soni; Vidhi Jain; Balamurugan Thirunavukkarasu; Deepak Vedant; Deepak Kumar; Pravin Kumar
Journal:  J Oral Maxillofac Surg Med Pathol       Date:  2022-04-04

6.  Experience on rhino-orbital mucormycosis from a tertiary care hospital in the first wave of COVID-19: An Indian perspective.

Authors:  Gunjan Saluja; Anju Bhari; Neelam Pushker; Sahil Agrawal; Rachna Meel; Alok Thakar; Immaculata Xess; Ankur Khandelwal; Anubhav Narwal; Mandeep S Bajaj
Journal:  Med J Armed Forces India       Date:  2022-04-02

7.  Epidemic of Mucormycosis in COVID-19 Pandemic: A Position Paper.

Authors:  Rahul Kulkarni; Usha K Misra; Chandrashekhar Meshram; Dhanpat Kochar; Manish Modi; Venugopalan Y Vishnu; Ravindra K Garg; Nirmal Surya
Journal:  Ann Indian Acad Neurol       Date:  2021-05-31       Impact factor: 1.383

8.  Utility of MGG and Papanicolaou stained smears in the detection of Mucormycosis in nasal swab/scraping/biopsy samples of COVID 19 patients.

Authors:  Ashish C Philip; Prarthna Madan; Sonal Sharma; Shukla Das
Journal:  Diagn Cytopathol       Date:  2021-12-29       Impact factor: 1.390

9.  Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations.

Authors:  Nurettin Bayram; Cemal Ozsaygılı; Hafize Sav; Yucel Tekin; Medine Gundogan; Emine Pangal; Ayse Cicek; İbrahim Özcan
Journal:  Jpn J Ophthalmol       Date:  2021-05-31       Impact factor: 2.447

10.  Management outcomes of mucormycosis in COVID-19 patients: A preliminary report from a tertiary care hospital.

Authors:  Abha Kumari; Nusumu Purnachandra Rao; Uma Patnaik; Virender Malik; Manvir Singh Tevatia; Shivali Thakur; Jijesh Jaydevan; Pavitra Saxena
Journal:  Med J Armed Forces India       Date:  2021-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.